Norway

Waiting Times for Substance Use Disorder Treatment in Norway

"Waiting times for treatment for drug and alcohol problems appear to be decreasing. The Norwegian National Patient Register publishes statistics every quarter of waiting times for treatment and violations of treatment guarantees. In interdisciplinary specialised treatment, the average waiting time in 2011 was 72 days for patients who were entitled to prioritised treatment (both alcohol and drug problems), a reduction of eight days from 2009. In the first four months of 2012, the waiting time decreased further to 66 days. The average waiting time for patients in mental

Access to Treatment and Waiting Times in Norway

"Pursuant to the Patients’ Rights Act, referrals to the specialist health service shall be assessed within 30 working days. In cases where the patient is granted a right to treatment, an individual deadline shall be set for when he/she shall receive the necessary treatment at the latest. A special waiting time guarantee for children and young people under the age of 23 with mental health problems or drug-related complaints stipulates that they shall be assessed within ten working days.

Availability of Opioid Substitution Treatment (OST) in Norway

"The Norwegian OST programme was established in 1998. It was run by 14 centres in the four health regions until 2010. Special guidelines were introduced from 1 January 2010, which emphasised, among other things, that OST should be integrated in the ordinary specialist health service (see NR 2010 Chapter 11). The basic model of a tripartite collaboration comprising social security offices, GPs and the specialist health service was retained, and the indication for OST shall be assessed by the specialist health service.

Prevalence of Injection Drug Use in Norway

"The estimated number of injecting drug users in Norway was also reported prior to the revision, using the mortality multiplier method. This method divides the number of drug-related deaths by the likelihood of dying of a drug-related diagnosis in the population of injectors in the 15–64 age group. First, an estimate of the number of recreational users was subtracted from the nominator because they are less likely to have injected the substance that caused the death.

Prevalence of Other Drug Use in Norway

"In line with a number of other studies, the 2013 survey shows that cannabis is by far the most common illegal drug in Norway. As shown in Figure 2, the LTP rate for cannabis use among all adults was 23.3 per cent, while the LYP rate was 5.1 per cent. By comparison, the LTP rate was estimated to be 4.2 per cent for cocaine, 3.7 per cent for amphetamines, 2.3 per cent for ecstasy, 1.5 per cent for LSD, 1.1 per cent for GHB/GBL and 0.7 per cent for heroin for all adults (Figure 3). The LYP rate was estimated to be less than one per cent for cocaine, amphetamines and ecstasy.

Prevalence of Cannabis Use in Norway

"By combining the data from 2012 and 2013, we can obtain more precise estimates of prevalence levels for cannabis use and differences between subgroups. The estimated LTP [lifetime prevalence], LYP [last year prevalence] and LMP [last month prevalence] rates among all adults (aged 16–64) were 21.3 per cent, 4.3 per cent and 1.6 per cent, respectively. Among young adults (aged 16–34), the corresponding LTP, LYP and LMP estimates are 30.2 per cent, 10 per cent and 3.4 per cent.

Drug Control Spending By Norwegian Government

"The Norwegian welfare model, which includes drug and alcohol policy, is based on rights and universal schemes under which benefits and services are provided according to needs and not symptoms. Expenditure on drug-related problems is divided between several budget chapters, mostly in the form of universal welfare services and rights irrespective of diagnosis. The uncertainty attached to calculating the size of drug-related expenditure is so great that it is simply not possible. In addition, there is a lot of grant funding for which ‘drugs’ is one of several purposes.

Norway's National Drug Control Strategy

"On 22 June 2012, the Government presented a white paper on drugs and alcohol policy.4 This is the first white paper setting out a comprehensive drugs and alcohol policy that covers alcohol, drugs, addictive medicinal drugs, and doping as a social problem. In the white paper, the Government presents targets and measures ranging from effective prevention, early intervention and help for people with extensive drug and alcohol problems to measures targeting next-of-kin and third parties affected by the harm caused by drug and alcohol use.

Drugged Driving Laws in Norway

"With effect from 1 February 2012, the Storting Implementation of the national action plan introduced ‘drug driving limits’ for 20 narcotic substances and potentially intoxicating medicinal drugs. Norway thereby became the first country in the world to set legal and sentencing limits for substances other than alcohol. The amendments to the Road Traffic Act entered

Pages